KIR2DL2 inhibitory pathway enhances Th17 cytokine secretion by NK cells in response to herpesvirus infection in multiple sclerosis patients

Journal of Neuroimmunology

Volumn 294, Issue , 2016, Pages 1-5

  Rizzo, Roberta ^a   Bortolotti, Daria ^a   Fainardi, Enrico ^b   Gentili, Valentina ^a   Bolzani, Silvia ^a   Baldi, Eleonora ^b   Casetta, Ilaria ^a   Granieri, Enrico ^a   Rotola, Antonella ^a   Furlan, Roberto ^c   Di Luca, Dario ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Herpesvirus; Host pathogens interactions; Inhibitory receptor; NK cells; Th17

Indexed keywords

GAMMA INTERFERON; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2; CYTOKINE; KIR2DL2 PROTEIN, HUMAN; MESSENGER RNA;

ADULT; ARTICLE; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ASSOCIATION; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; INFECTION SENSITIVITY; MALE; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TH17 CELL; VIRUS TITRATION; CELL CULTURE; GENETICS; LYMPHOCYTE ACTIVATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PROCEDURES; VIROLOGY; VIRUS LOAD;

ADULT; CELLS, CULTURED; CYTOKINES; FEMALE; HERPES SIMPLEX; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; RECEPTORS, KIR2DL2; RNA, MESSENGER; TH17 CELLS; VIRAL LOAD;

EID: 84961753017     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2016.03.007     Document Type: Article

References (23)

1. Abeyweera T.P., Merino E., Huse M. Inhibitory signaling blocks activating receptor clustering and induces cytoskeletal retraction in natural killer cells. J. Cell Biol. 2011, 192:675.
2. Ben Fredj N., Rizzo R., Bortolotti D., Nefzi F., Chebel S., Rotola A., Frih-Ayed M., Di Luca D., Aouni M. Evaluation of the implication of KIR2DL2 receptor in multiple sclerosis and herpesvirus susceptibility. J. Neuroimmunol. 2014, 271:30-35.
3. Cassidy S., Mukherjee S., Myint T.M., Mbiribindi B., North H., Traherne J., Mulder A., Claas F.H., Purbhoo M.A., Das J., Khakoo S.I. Peptide selectivity discriminates NK cells from KIR2DL2- and KIR2DL3-positive individuals. Eur. J. Immunol. 2015, 45:492-500.
4. Döhring C., Scheidegger D., Samaridis J., Cella M., Colonna M. A human killer inhibitory receptor specific for HLA-A1,2. J. Immunol. 1996, 156:3098-3101.
5. Estefania E., Gómez-Lozano N., Portero F., de Pablo R., Solís R., Sepúlveda S., Vaquero M., Gonzále M.A., Suárez E., Roustán G., Vilches C. Influence of KIR gene diversity on the course of HSV-1 infection: resistance to the disease is associated with the absence of KIR2DL2 and KIR2DS2. Tissue Antigens 2007, 70:34-41.
6. Han L., Yang J., Wang X., Li D., Lv L., Li B. Th17 cells in autoimmune diseases. Front Med. 2015, 9:10-19.
7. Hao J., Liu R., Piao W., Zhou Q., Vollmer T.L., Campagnolo D.I., Xiang R., La Cava A., Van Kaer L., Shi F.D. Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology. J. Exp. Med. 2010, 207:1907-1921.
8. Hou W., Kang H., Kim B.S. Th17 cells enhance viral persistence and inhibit T cell cytotoxicity in a model of chronic virus infection. J. Exp. Med. 2009, 206:313-328.
9. Jiang W., Chai N., Mari D., Bielekova B. Unexpected role for granzyme K in CD56bright NK cell-mediated immunoregulation of multiple sclerosis. J. Immunol. 2011, 187:781-790.
10. Kaur G., Trowsdale J., L.Fugger Natural killer cells and their receptors in multiple sclerosis. Brain 2013, 136:2657-2676.
11. Kurtzke J.F. On the origin of EDSS. Mult Scler Relat Disord. 2015, 4:95-103.
12. Litwin V., Gumperz J., Parham P., Phillips J.H., Lanier L.L. NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules. J. Exp. Med. 1994, 180:537-543.
13. Lublin F.D. 2015. New multiple sclerosis phenotypic classification. Eur. Neurol. 2014, 72:1-5.
14. Moraru M., Cisnerus E., Gómez-Lozano N., de Pablo R., Portero F., Cañizares M., Vaquero M., Roustán G., Millán I., López-Botet M., Vilches C. Host genetic factors in susceptibility to herpes simplex type 1 virus infection: contribution of polymorphic genes at the interface of innate and adaptive immunity. J. Immunol. 2012, 188:4412-4420.
15. Moretta A., Bottino C., Pende D., Tripodi G., Tambussi G., Viale O., Orengo A., Barbaresi M., Merlij A., Ciccone E., L.Moretta Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J. Exp. Med. 1990, 172:1589-1598.
16. Moretta A., Vitale M., Bottino C., Orengo A.M., Morelli L., Augugliaro R., Barbaresi M., Ciccone E., Moretta L. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J. Exp. Med. 1993, 178:597-604.
17. Pandya A., Al-Jaderi J.Z., Høglund R.A., Holmøy T., Harbo H.F., Norgauer J., Maghazachi A.A. Identification of human NK17/NK1 cells. PLoS One 2011, 6:e26780.
18. Pende D., Biassoni R., Cantoni C., Verdiani S., Falco M., di Donato C., Accame L., Bottino C., Moretta A., Moretta L. The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. J. Exp. Med. 1996, 184:505-518.
19. Polman C.H., Rudick R.A. The multiple sclerosis functional composite: a clinically meaningful measure of disability. Neurology 2010, 74:S8-15.
20. Rizzo R., Gentili V., Casetta I., Caselli E., De Gennaro R., Granieri E., Cassai E., Di Luca D., Rotola A. Altered natural killer cells' response to herpes virus infection in multiple sclerosis involves KIR2DL2 expression. J. Neuroimmunol. 2012, 251:55-64.
21. Rodríguez-Martín E., Picón C., Costa-Frossard L., Alenda R., Sainz de la Maza S., Roldán E., Espiño M., Villar L.M., Álvarez-Cermeño J.C. Natural killer cell subsets in cerebrospinal fluid of patients with multiple sclerosis. Clin. Exp. Immunol. 2015, 180:243-249.
22. Strowig T., Brilot F., Arrey F., Bougras G., Thomas D., Muller W.A., Münz C. Tonsilar NK cells restrict B cell transformation by the Epstein-Barr virus via IFN-gamma. PLoS Pathog. 2008, 4:e27.
23. Williams H., McAulay K., Macsween K.F., Gallacher N.J., Higgins C.D., Harrison N., Swerdlow A.J., Crawford D.H. The immune response to primary EBV infection: a role for natural killer cells. Br. J. Haematol. 2005, 129:266-274.